News | May 12, 2015

Men with High Estrogen Levels Could Be at Greater Risk of Breast Cancer

International study suggests causal connection, but exact mechanism for cancer growth remains unknown

men, breast cancer, high estrogen levels, Cancer Research UK

May 12, 2015 — Men with naturally high levels of estrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK. The study was published in the Journal of Clinical Oncology.

This is the first time a link between estrogen levels in the blood and male breast cancer has been identified, despite the hormone’s connection to breast, womb and ovarian cancers in women.

Men with the highest levels of estrogen were two and a half times more likely to develop breast cancer than men with the lowest levels of the hormone.

Male breast cancer is very rare, with one man in every 100,000 diagnosed with breast cancer each year in the U.K. Around 350 male cases are diagnosed each year in the U.K. compared with nearly 50,000 cases of breast cancer in women.

The research at the National Cancer Institute in the United States was part of an international collaboration between Cancer Research UK, the National Cancer Institute and others.

The aim was to study a large international pool of men with breast cancer. The research compared estrogen levels in 101 men who went on to develop breast cancer with 217 healthy men.

Mark Cross, 46, a police officer from Cambridgeshire, was diagnosed with breast cancer in 2009. He had a mastectomy and then follow-up treatment of chemotherapy and radiotherapy. His treatment ended in September 2010. He said: "The police sometimes get a bit of a reputation for being macho but I had great support from everyone within the Metropolitan police service. Not many people know that men get breast cancer too and it was a complete surprise to be diagnosed. My advice to all men is if you develop a lump on your chest — or anywhere else on your body — get it checked by your doctor as soon as possible. I hope my experience will raise awareness for other men."

Study author Prof. Tim Key, Cancer Research UK's hormone and nutrition expert at the University of Oxford, said: "We've shown for the first time that just like some forms of the cancer in women, estrogen has a big role to play in male breast cancer. So now the challenge is to find out exactly what this hormone is doing to trigger this rare form of the disease in men, and why some men have higher levels of estrogen in their blood. Our discovery is a crucial step forward in understanding the factors behind male breast cancer."

The symptoms, diagnosis and treatment of male breast cancer are very similar to breast cancer in women. The main risk of developing the disease in men is age, and almost eight in 10 cases are diagnosed in those aged 60 and older.

Julie Sharp, M.D., head of health information at Cancer Research UK, said: "Breast cancer in men isn't discussed very often, so a diagnosis can be a big shock for the small group of men who develop the disease.

"Some of the estrogen variation in men will simply be natural, but for others there may be a link to being overweight. Fat cells in the body are thought to drive up the body's level of this hormone in men and women, so this is another good reason to try and keep a healthy weight.

"This early research is crucial in understanding why these men get breast cancer - so that one day we can treat it more effectively."

For more information: www.cancerresearchuk.org

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...